Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $47.3M |
| Sales growthchange from the year before | +49.6% |
| Gross marginshare of sales left after the direct cost of what it sells | 76.5% |
| Operating marginshare of sales left after running the business | -55.6% |
| Net marginshare of sales kept as profit | -85.3% |
| Free-cash-flow marginspare cash generated per $100 of sales | -76.1% |
| Return on invested capitalprofit made on each $100 put into the business | -13.3% |
| Return on equityprofit vs. shareholders' accounting value | -28.7% |
| Debt / equitydebt vs. shareholders' accounting value | 0.11 |
| Change in share countnegative = the company is buying back its shares | +13340.5% |
1 insider sold $3.6M on the open market.
| Gilde Healthcare Holding B.V.10% owner | SoldAug 4 | 99,812 shat $22.77 · $2.3M |
| Gilde Healthcare Holding B.V.10% owner | SoldAug 3 | 10,751 shat $22.71 · $244K |
| Gilde Healthcare Holding B.V.10% owner | SoldJul 31 | 20,034 shat $22.73 · $455K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy